| Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108) |
|---|
| 01/29/2004 | US20040016063 1,3-Dihydroxybenzene derivatives and colorants containing said compounds |
| 01/29/2004 | CA2492907A1 Phosphodiesterase 4 inhibitors, including n-substituted aniline and diphenylamine analogs |
| 01/29/2004 | CA2492906A1 Materials and methods for treating hypercholesterolemia |
| 01/28/2004 | EP1384475A1 Liver funcion protecting or ameliorating agent |
| 01/28/2004 | EP1383757A1 Antagonists of mcp-1 function and methods of use thereof |
| 01/28/2004 | EP1383755A2 Separation of 2,5-dihydrofuran and water from mixtures thereof by extractive distillation |
| 01/28/2004 | EP1383731A1 Biaryl compounds as serine protease inhibitors |
| 01/28/2004 | CN1471521A Amino alkoxybenzoyl-benzofuran or benzothiophene derivatives, methods for preparing same and compositions containing same |
| 01/28/2004 | CN1471520A Aminoalkyl benzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same |
| 01/28/2004 | CN1471519A Amino alkyenylbenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same |
| 01/28/2004 | CN1471494A Rare earth or gallium additive composition, methods for preparing same and use thereof as catalyst |
| 01/28/2004 | CN1471430A Catalyst and method for producing maleic anhydride |
| 01/28/2004 | CN1470491A Method for removing impurities from oxidation products |
| 01/28/2004 | CN1136218C Process for preparing 3-(substituted phenyl)-5-(thienyl or fully)-1,2,4-triazoles and novel intermediates utilized therein |
| 01/28/2004 | CN1136210C High-speed countercurrent chromatographic process of separating and purifying tanshinol |
| 01/28/2004 | CN1136209C Process for preparing optically active 3-n-butyl phenylphthaleine |
| 01/28/2004 | CN1136208C Intermediate for preparing 2-thiosubstituted carbapenems |
| 01/28/2004 | CN1136207C Catalyst for preparing lactone and process for preparing lactone |
| 01/27/2004 | US6683648 Enzyme inhibitors such as 2s-(((dimethylamino)acetyl)amino)-n-(3-((((2-hydroxy-1,1 -dimethylethyl)amino)sulfonyl)(3-methyl butyl)amino)-2r-hydroxy-1s-(phenylmethyl)-propyl)-3,3-dimethyl butanamide, used for prohylaxis of viral diseases |
| 01/27/2004 | US6683215 N-(4-carbamimidoyl-phenyl)-glycine derivatives |
| 01/27/2004 | US6683211 Fungicides for crops |
| 01/27/2004 | US6683201 Analine derivatives as OSC inhibitors |
| 01/27/2004 | US6683195 Enantiomeric compounds for treatment of cardiac arrhythmias and methods of use |
| 01/27/2004 | US6683113 (R)-chiral halogenated substituted N,N-Bis-benzyl aminioalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 01/27/2004 | US6683107 Furans, benzofurans, and thiophenes useful in the treatment of insulin resistance and hyperglycemia |
| 01/27/2004 | US6683099 Substituted N,N-disubstituted cycloalkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 01/27/2004 | US6683074 Cyclic amine derivatives-CCR-3 receptor antagonists |
| 01/27/2004 | US6683068 For therapy of tetracycline compound-responsive states, such as bacterial infections and neoplasms |
| 01/27/2004 | CA2256247C New naphtalene compounds, their preparation and pharmaceutical compositions containing them |
| 01/27/2004 | CA2112414C 4-hydroxy-2'-nitrobutyrophenone and tetrahydro-2-(o-nitrophenyl)-2-furanol useful as intermediates in the preparation of a crop-selective herbicide |
| 01/22/2004 | WO2004007504A1 Heterobicyclic pyrazole derivatives as kinase inhibitors |
| 01/22/2004 | WO2004007474A1 Method for the separation of ascorbic acid from a polar solvent containing ascorbic acid and 2-keto-l-gulonic acid |
| 01/22/2004 | WO2004007459A2 Naphthol, quinoline and isoquinoline-derivatives as modulators of vanilloid vr1 receptor |
| 01/22/2004 | WO2004007455A1 Heterocyclically substituted benzoylureas, method for their production and their use as medicaments |
| 01/22/2004 | WO2004007439A1 Biaryl derivatives |
| 01/22/2004 | WO2004006835A2 Novel compounds, pharmaceutical compositions containing same, and methods of use for same |
| 01/22/2004 | US20040014997 Process for the preparation of citalopram |
| 01/22/2004 | US20040014993 Chemical intermediates, starting o-dimethoxybenzene, ketalization, esterification, reduction, hydroxylation, bio-reduction by a microorganism, cyclization; biocatalysis to produce optically enantiomer, use Baker's yeast |
| 01/22/2004 | US20040014990 Preparation of maleic anhydride and catalyst for this purpose |
| 01/22/2004 | US20040014971 N-(4-(4-(2-oxo-1-phenyl-2-((2,2,2-trifluoroethyl)amino)ethyl)-1 -piperazinyl)-phenyl)-4'-(trifluoromethyl)-(1,1'-biphenyl)-2-carboxamide for treatment of obesity, diabetes, and cardiovascular disorders; decreases apoplioprotein secretion |
| 01/22/2004 | US20040014969 Such as methyl-4'-(4-((8-(acetylamino)ethyl)-2-naphthyl)oxy) butoxy)-(1,1'-biphenyl)-4-carboxylate; for treating/ preventing melatoninergic disorders |
| 01/22/2004 | US20040014807 Phenalenone derivatives, processes for preparation and use thereof |
| 01/22/2004 | US20040014801 Thio semicarbazone and semicarbazone inhibitors of cysteine proteases and methods of their use |
| 01/22/2004 | US20040014796 Antiinflammatory agents; rheumatic diseases; antitumor agents |
| 01/22/2004 | US20040014787 Hormone inhibitors; controlling fertility |
| 01/22/2004 | US20040014758 Benzylcycloalkyl amines as modulators of chemokine receptor activity |
| 01/22/2004 | CA2493374A1 Heterocyclically substituted benzoylureas, method for their production and their use as medicaments |
| 01/22/2004 | CA2492673A1 Heterobicyclic pyrazole derivatives as kinase inhibitors |
| 01/22/2004 | CA2492155A1 Method for the separation of ascorbic acid from a polar solvent containing ascorbic acid and 2-keto-l-gulonic acid |
| 01/22/2004 | CA2491183A1 Novel compounds, pharmaceutical compositions containing same, and methods of use for same |
| 01/21/2004 | EP1381590A1 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 01/21/2004 | EP1381369A1 Use of selective cox-2 inhibitors for the treatment of urinary incontinence |
| 01/21/2004 | EP1381366A2 Indole, azaindole and related heterocyclic amidopiperazine derivatives |
| 01/21/2004 | EP1381359A1 Aurones as telomerase inhibitors |
| 01/21/2004 | EP1305028A4 Antimicrobial biaryl compounds |
| 01/21/2004 | EP1257265B1 Use of 2-phenylene diamine derivatives for the treatment of infections |
| 01/21/2004 | EP1229791B1 Active ingredient combination having insecticidal and acaricidal characteristics |
| 01/21/2004 | EP0937048B1 HETEROCYCLE DERIVATIVES WHICH INHIBIT FACTOR Xa |
| 01/21/2004 | EP0811002B1 Benzylpiperidines and piperazines as muscarinic antagonists |
| 01/21/2004 | CN1469861A Process for the preparation of thiophenols |
| 01/21/2004 | CN1469748A Pharmaceutical compositions for topical delivery of cyclooxygenase-2 enzyme inhibitors |
| 01/21/2004 | CN1468594A Composition containing at least one oxidative sensitive hydrophilic active ingredient through at least one maleic anhydride copolymer stabilization |
| 01/20/2004 | US6680392 Process for removing polysorbitols from sorbitan esters |
| 01/20/2004 | US6680389 Acrylic esters containing fluorine at alpha-position and having a lactone ring introduced into the ester side chain thereof; useful as monomers to produce base polymers for use in chemically amplified resist compositions |
| 01/20/2004 | US6680337 Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| 01/20/2004 | US6680321 4-((1-piperazinylmethyl)-benzamide derivatives; hypotensive agents; immunomodulators |
| 01/20/2004 | US6680318 Piperazinomethylbenzamides as delta-opioid receptor agonists |
| 01/20/2004 | CA2191893C Process for the preparation of heterocyclic aldehydes |
| 01/15/2004 | WO2004005274A1 Benzoprostacyclin intermediates and methods for their preparation |
| 01/15/2004 | WO2004005273A1 Manufacture of 3-methyl-tetrahydrofuran from alpha-methylene-gamma-butyrolactone in a two step process |
| 01/15/2004 | WO2004005272A1 Manufacture of 3-methyl-tetrahydrofuran from alpha-methylene-gamma-butyrolactone in a single step process |
| 01/15/2004 | WO2004005271A1 Manufacture of 3-methyl-tetrahydrofuran from 2-methyl-gamma-butyrolactone |
| 01/15/2004 | WO2004005239A1 PROCESS FOR THE PREPARATION OF N-MONOSUBSTITUTED β-AMINO ALCOHOLS |
| 01/15/2004 | WO2004004729A1 Utilization of heteroarene carboxamide as dopamine-d3 ligands for the treatment of cns diseases |
| 01/15/2004 | WO2004004712A1 Methods of treating microbial infections in humans and animals |
| 01/15/2004 | WO2002055025A3 Compounds, methods and compositions useful for the treatment of bovine viral diarrhea virus (bvdv) infection and hepatitis c virus (hcv) infection |
| 01/15/2004 | US20040010153 Manufacture of 3-methyl-tetrahydrofuran from alpha-methylene-gamma-butyrolactone in a single step process |
| 01/15/2004 | US20040010152 Catalytic oxidation of a cyclic ketone compound |
| 01/15/2004 | US20040010149 Ligand for transition metal complex catalyst |
| 01/15/2004 | US20040010040 Granulation; free-flowing; absorption of butyric acid on carrier; salt formation; acidification adjuvant for animal feeds |
| 01/15/2004 | US20040010033 N-cyclohexylmethyl- or N-benzyl-5-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphth-2-yl)furan-2 -carboxamide derivatives; suppression of gonadotropin release to treat hormone dependant tumors and reproductive disorders |
| 01/15/2004 | US20040010032 Intermediate for dronedarone. |
| 01/15/2004 | US20040010020 Trifluoromethyl-substituted nitrogen compounds; treating type II diabetes, obesity, cardiovascular diseases, hypertension, arteriosclerosis, neurological diseases, adrenal and pituitary tumors, and glaucoma |
| 01/15/2004 | US20040010011 Aminoalkoxybenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same |
| 01/15/2004 | US20040009979 Use of compounds for the elevation of pyruvate dehydrogenase activity |
| 01/15/2004 | US20040009923 Alpha-substituted methyl ketones derived from aspartic acid and the closed hemi-ketal forms thereof |
| 01/15/2004 | US20040009890 Structure-based design of a drug that can act as an inhibitor of at least two different biological entities using computer modeling; useful for designing HIV protease inhibitors and antineoplastic agents and where drug resistance may exist. |
| 01/15/2004 | US20040009573 Pestalotiopsis microsporia isolates and compounds derived therefrom |
| 01/15/2004 | DE10228407A1 Verfahren zur Herstellung von 2-Acetyl-2-chlor-gamma-butyrolacton durch Umsetzung von 2-Acetyl-gamma-butyrolacton Salz mit Chlor in Gegenwart von Wasser A process for preparing 2-acetyl-2-chloro-gamma-butyrolactone by reaction of 2-acetyl-gamma-butyrolactone salt with chlorine in the presence of water |
| 01/15/2004 | CA2491573A1 Methods of treating microbial infections in humans and animals |
| 01/15/2004 | CA2489396A1 Utilization of heteroarene carboxamide as dopamine-d3 ligands for the treatment of cns diseases |
| 01/14/2004 | EP1380564A1 Binaphtol derivative and process for producing the same |
| 01/14/2004 | EP1380562A1 Carboxylic acid derivative and salt thereof |
| 01/14/2004 | EP1380558A1 Process for production of dimers of aromatic monohydroxyl compounds |
| 01/14/2004 | EP1379516A1 Alkoxycarbonylamino benzoic acid or alkoxycarbonylamino tetrazolyl phenyl derivatives as ip antagonists |
| 01/14/2004 | EP1379498A1 Sulphones which modulate the action of gamma secretase |
| 01/14/2004 | EP1379493A2 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses |
| 01/14/2004 | EP1379239A2 N-(2-arylethyl) benzylamines as antagonists of the 5-ht6 receptor |
| 01/14/2004 | EP1265882B1 Method for the preparation of citalopram |
| 01/14/2004 | CN1468227A Non-imidazole aryloxyalkylamines |